Rachel V. Stankowski

1.6k total citations
26 papers, 1.2k citations indexed

About

Rachel V. Stankowski is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rachel V. Stankowski has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rachel V. Stankowski's work include Metabolism, Diabetes, and Cancer (7 papers), Global Cancer Incidence and Screening (6 papers) and Cancer Risks and Factors (5 papers). Rachel V. Stankowski is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Global Cancer Incidence and Screening (6 papers) and Cancer Risks and Factors (5 papers). Rachel V. Stankowski collaborates with scholars based in United States, Australia and Sweden. Rachel V. Stankowski's co-authors include Jessica M. Engel, Adedayo A. Onitilo, Suhail A.R. Doi, Robert A. Kloner, Shereif H. Rezkalla, Gail Williams, Ingrid Glurich, Jennifer M. Hanna, Hong Liang and Richard L. Berg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Roentgenology.

In The Last Decade

Rachel V. Stankowski

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel V. Stankowski United States 17 448 331 315 238 183 26 1.2k
Susannah Stanway United Kingdom 16 681 1.5× 242 0.7× 386 1.2× 129 0.5× 82 0.4× 38 1.5k
Jane Yanagawa United States 18 415 0.9× 336 1.0× 156 0.5× 207 0.9× 163 0.9× 57 1.3k
David C. Muller United Kingdom 25 250 0.6× 660 2.0× 212 0.7× 268 1.1× 254 1.4× 62 1.9k
Cheryl Lewis United States 21 264 0.6× 826 2.5× 396 1.3× 327 1.4× 295 1.6× 53 1.7k
Anne M. Deschamps United States 18 276 0.6× 570 1.7× 766 2.4× 330 1.4× 269 1.5× 27 1.7k
Chan Zeng United States 27 423 0.9× 748 2.3× 155 0.5× 141 0.6× 195 1.1× 63 2.4k
Susan Dent Canada 27 1.1k 2.4× 315 1.0× 259 0.8× 495 2.1× 206 1.1× 81 2.1k
Jennifer Kim United States 22 326 0.7× 324 1.0× 139 0.4× 174 0.7× 336 1.8× 88 1.9k
Ilaria Portarena Italy 23 803 1.8× 567 1.7× 66 0.2× 273 1.1× 130 0.7× 59 1.4k
Saroj Niraula Canada 19 1.1k 2.4× 735 2.2× 170 0.5× 584 2.5× 198 1.1× 49 2.0k

Countries citing papers authored by Rachel V. Stankowski

Since Specialization
Citations

This map shows the geographic impact of Rachel V. Stankowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel V. Stankowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel V. Stankowski more than expected).

Fields of papers citing papers by Rachel V. Stankowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel V. Stankowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel V. Stankowski. The network helps show where Rachel V. Stankowski may publish in the future.

Co-authorship network of co-authors of Rachel V. Stankowski

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel V. Stankowski. A scholar is included among the top collaborators of Rachel V. Stankowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel V. Stankowski. Rachel V. Stankowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stankowski, Rachel V., et al.. (2021). Cardiovascular Health and Disease in the Context of COVID-19. Cardiology Research. 12(2). 67–79. 16 indexed citations
2.
Rezkalla, Shereif H., Rachel V. Stankowski, Jennifer M. Hanna, & Robert A. Kloner. (2017). Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC: Cardiovascular Interventions. 10(3). 215–223. 166 indexed citations
3.
Doi, Suhail A.R., Luis Furuya‐Kanamori, Jessica M. Engel, et al.. (2016). The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study. Cancer Causes & Control. 27(7). 941–946. 5 indexed citations
4.
Stankowski, Rachel V., et al.. (2016). Adverse Childhood Experiences and Health in Adulthood in a Rural Population-Based Sample. Clinical Medicine & Research. 14(3-4). 126–137. 55 indexed citations
5.
Onitilo, Adedayo A., Jessica M. Engel, Rachel V. Stankowski, & Suhail A.R. Doi. (2014). Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research. 13(2). 65–73. 95 indexed citations
6.
Stankowski, Rachel V., et al.. (2014). Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence. Current Pharmaceutical Design. 20(30). 4879–4898. 108 indexed citations
7.
Onitilo, Adedayo A., et al.. (2014). Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis. Rural and Remote Health. 14(3). 2738–2738. 34 indexed citations
8.
Stankowski, Rachel V., et al.. (2014). PS2-42: All-cause Mortality is Decreased in Women Undergoing Annual Mammography Screening Before Breast Cancer Diagnosis. Clinical Medicine & Research. 12(1-2). 81–81. 1 indexed citations
9.
Stankowski, Rachel V., Robert A. Kloner, & Shereif H. Rezkalla. (2014). Cardiovascular consequences of cocaine use. Trends in Cardiovascular Medicine. 25(6). 517–526. 68 indexed citations
10.
Onitilo, Adedayo A., Rachel V. Stankowski, Richard L. Berg, et al.. (2014). A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record. BMC Medical Informatics and Decision Making. 14(1). 38–38. 6 indexed citations
11.
Onitilo, Adedayo A., Rachel V. Stankowski, Jessica M. Engel, et al.. (2013). Type 2 diabetes mellitus, glycemic control, and cancer risk. European Journal of Cancer Prevention. 23(2). 134–140. 59 indexed citations
12.
Onitilo, Adedayo A., Rachel V. Stankowski, Jessica M. Engel, et al.. (2013). Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women. European Journal of Cancer Prevention. 23(2). 76–83. 36 indexed citations
13.
Berg, Richard L., Jessica M. Engel, Rachel V. Stankowski, et al.. (2013). Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 11(4). 201–209. 18 indexed citations
14.
Donald, Maria, et al.. (2013). Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study. Clinical Medicine & Research. 11(4). 210–218. 10 indexed citations
15.
Onitilo, Adedayo A., et al.. (2013). A Core-Item Reviewer Evaluation (CoRE) System for Manuscript Peer Review. Accountability in Research. 21(2). 109–121. 14 indexed citations
16.
Onitilo, Adedayo A., Richard L. Berg, Jessica M. Engel, et al.. (2013). Increased Risk of Colon Cancer in Men in the Pre-Diabetes Phase. PLoS ONE. 8(8). e70426–e70426. 15 indexed citations
17.
Onitilo, Adedayo A., Rachel V. Stankowski, Jessica M. Engel, & Suhail A.R. Doi. (2013). Adequate lymph node recovery improves survival in colorectal cancer patients. Journal of Surgical Oncology. 107(8). 828–834. 30 indexed citations
18.
Onitilo, Adedayo A., Jessica M. Engel, Ingrid Glurich, et al.. (2012). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes & Control. 23(7). 991–1008. 68 indexed citations
19.
Onitilo, Adedayo A., Jessica M. Engel, Ingrid Glurich, et al.. (2012). Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes & Control. 23(6). 967–981. 93 indexed citations
20.
Onitilo, Adedayo A., Jessica M. Engel, Rachel V. Stankowski, et al.. (2012). High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. Breast Cancer Research and Treatment. 134(1). 291–298. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susannah Stanway Breakdown of academic impact, for papers by Jane Yanagawa Breakdown of academic impact, for papers by David C. Muller Breakdown of academic impact, for papers by Cheryl Lewis Breakdown of academic impact, for papers by Anne M. Deschamps Breakdown of academic impact, for papers by Chan Zeng Breakdown of academic impact, for papers by Susan Dent Breakdown of academic impact, for papers by Jennifer Kim Breakdown of academic impact, for papers by Ilaria Portarena Breakdown of academic impact, for papers by Saroj Niraula
Rankless by CCL
2026